Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A bat MERS-like coronavirus circulates in pangolins and utilizes human DPP4 and host proteases for cell entry
Jing Chen, Xing‐Lou Yang, Hao-Rui Si, et al.
Cell (2023) Vol. 186, Iss. 4, pp. 850-863.e16
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

Virus diversity, wildlife-domestic animal circulation and potential zoonotic viruses of small mammals, pangolins and zoo animals
Xinyuan Cui, Kewei Fan, Xianghui Liang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 45
The Emergence and Evolution of SARS-CoV-2
Edward C. Holmes
Annual Review of Virology (2024) Vol. 11, Iss. 1, pp. 21-42
Closed Access | Times Cited: 25
Human coronavirus HKU1 recognition of the TMPRSS2 host receptor
Matthew McCallum, Young‐Jun Park, Cameron Stewart, et al.
Cell (2024) Vol. 187, Iss. 16, pp. 4231-4245.e13
Open Access | Times Cited: 16
Multiple independent acquisitions of ACE2 usage in MERS-related coronaviruses
Chengbao Ma, Chen Liu, Young‐Jun Park, et al.
Cell (2025)
Open Access | Times Cited: 3
Molecular basis of convergent evolution of ACE2 receptor utilization among HKU5 coronaviruses
Young‐Jun Park, Chen Liu, Jimin Lee, et al.
Cell (2025)
Closed Access | Times Cited: 3
Bat-infecting merbecovirus HKU5-CoV lineage 2 can use human ACE2 as a cell entry receptor
Jing Chen, Wei Zhang, Yang Li, et al.
Cell (2025)
Closed Access | Times Cited: 1
A MERS-CoV antibody neutralizes a pre-emerging group 2c bat coronavirus
Longping V. Tse, Yixuan J. Hou, Elizabeth McFadden, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 715
Open Access | Times Cited: 23
Anticipating a MERS-like coronavirus as a potential pandemic threat
Alimuddin Zumla, Malik Peiris, Ziad A. Memish, et al.
The Lancet (2024) Vol. 403, Iss. 10438, pp. 1729-1731
Closed Access | Times Cited: 11
Functional assessment of cell entry and receptor use for merbecoviruses
Nicholas Catanzaro, Ziyan Wu, Chengcheng Fan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 8
Recombination analysis on the receptor switching event of MERS-CoV and its close relatives: implications for the emergence of MERS-CoV
Jarel Elgin Tolentino, Spyros Lytras, Jumpei Ito, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 8
Mapping immunodominant sites on the MERS-CoV spike glycoprotein targeted by infection-elicited antibodies in humans
Amin Addetia, Cameron Stewart, Albert J. Seo, et al.
Cell Reports (2024) Vol. 43, Iss. 8, pp. 114530-114530
Open Access | Times Cited: 8
Human coronavirus HKU1 recognition of the TMPRSS2 host receptor
Matthew McCallum, Young‐Jun Park, Cameron Stewart, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 7
Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses
Yang Yang, Fang Li, Lanying Du
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Genomic screening of 16 UK native bat species through conservationist networks uncovers coronaviruses with zoonotic potential
Cedric C.S. Tan, Jahcub Trew, Thomas P. Peacock, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 20
Broad host tropism of ACE2-using MERS-related coronaviruses and determinants restricting viral recognition
Chengbao Ma, Chen Liu, Qing Xiong, et al.
Cell Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 17
ACE2-using merbecoviruses: Further evidence of convergent evolution of ACE2 recognition by NeoCoV and other MERS-CoV related viruses
Qing Xiong, Chengbao Ma, Chen Liu, et al.
Cell Insight (2024) Vol. 3, Iss. 1, pp. 100145-100145
Open Access | Times Cited: 5
Mapping immunodominant sites on the MERS-CoV spike glycoprotein targeted by infection-elicited antibodies in humans
Amin Addetia, Cameron Stewart, Albert J. Seo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
Animal models of Long Covid: A hit-and-run disease
Alexandra Schaefer, Sarah R. Leist, John M. Powers, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 773
Open Access | Times Cited: 5
Dysregulation of lung epithelial cell homeostasis and immunity contributes to Middle East respiratory syndrome coronavirus disease severity
Amy Sims, Alexandra Schaefer, Kenichi Okuda, et al.
mSphere (2025)
Open Access
ACE2 utilization of HKU25 clade MERS-related coronaviruses with broad geographic distribution
Chen Liu, Young‐Jun Park, Chengbao Ma, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Engineered DPP4 decoy confers broad-spectrum inhibition of MERS-CoV infection
Keisuke Nishioka, Yusuke Sakai, Daisuke Motooka, et al.
(2025), pp. 100018-100018
Open Access
Viral infections at the animal–human interface—Learning lessons from the SARS‐CoV‐2 pandemic
Harald Brüssow
Microbial Biotechnology (2023) Vol. 16, Iss. 7, pp. 1397-1411
Open Access | Times Cited: 12
Pandemic preparedness: On the efficacy of non‐pharmaceutical interventions in COVID‐19 and about approaches to predict future pandemic viruses
Harald Brüssow
Microbial Biotechnology (2024) Vol. 17, Iss. 3
Open Access | Times Cited: 4
Pathogenicity, tissue tropism and potential vertical transmission of SARSr-CoV-2 in Malayan pangolins
Xianghui Liang, Xiaohong Chen, Junqiong Zhai, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 5, pp. e1011384-e1011384
Open Access | Times Cited: 11
An engineered recombinant protein containing three structural domains in SARS-CoV-2 S2 protein has potential to act as a pan-human coronavirus entry inhibitor or vaccine antigen
Xinling Wang, Lujia Sun, Zezhong Liu, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top